Instructions for Bifiform (enterococcus faecium, bifidobacterium longum)
English Product Name
Bifiform®
Release Form
Intestinal soluble capsules
Description Bifiform
Intestinal soluble, solid gelatin capsules, No. 3, white or almost white; capsule contents are white to light yellow powder.
1 caps.
Enterococcus faecium not less than107 KOE
Bifidobacterium longum not less than 107 COE
ATX codes
A07FA Antidiarrheal drugs of biological origin, regulating the balance of intestinal microflora
Clinical and pharmacological groups / Group affiliation
A drug that regulates the balance of intestinal flora (a probiotic)
Active ingredient Bifiform
- Bifidobacterium longum
- Enterococcus faecium
Pharmacotherapeutic group Bifiform
MIBP eubiotic
Retention conditions
In a dry place at a temperature not exceeding 25 °C. Keep away from children.
Expiration date
Shelf life - 2 years.
Pharmacological effect Bifiform
Eubiotic - a drug that has a normalizing effect on the microflora of the intestine. Its pharmacological effect is caused by the presence of strains of Enterococcus faecium and Bifidobacterium longum - natural symbiotic bacteria that inhabit the gastrointestinal tract. These components of the preparation exhibit high activity in the fight against pathogenic and opportunistic microorganisms, and also activate the gut immunity.
Bifidobacterium longum is characterized by high intestinal survival and rapid growth. The presence of the apathogenic enterococcus Enterococcus faecium in the preparation also allows positive effects on the condition and function of both the large and small intestines, especially in the presence of fermentation dyspepsia and flatulence.
The drug is recommended to use Bifiform:
to treat and prevent various digestive disorders such as diarrhea caused by acute or chronic gastroenteritis, rotavirus infection, antibiotic-associated diarrhea, and traveler's diarrhea. It is also effective in the complex treatment of acute intestinal infections and chronic gastrointestinal diseases.
Method of application Bifiform
If the intestinal flora is normal and the immune system is maintained in children over 2 years and adults, the drug should be taken for 10 to 21 days. For lactose-intolerant patients, a lower dose of the drug is recommended—3 times a day. For treatment of cure, 2 capsules should be taken twice a day for two weeks. For children who are 2 years old or older, 2 to 3 capsules a day are used. If the infant cannot swallow the capsule, the contents should be mixed with a small amount of fluid.
- Nosology (ICD codes)
- A02
- Other salmonella infections
- A03
- Shigellosis
- A04
- Other bacterial intestinal infections
- A05
- Other bacterial food poisonings not elsewhere classified
- A08.0
- Enteritis due to rotavirus
- A09
- Other gastroenteritis and colitis of infectious and unspecified origin
- B98.0
- Helicobacter pylori as a cause of diseases classified elsewhere
- E73
- Lactose intolerance
- K52
- Other noninfectious gastroenteritis and colitis
- K58
- Irritable bowel syndrome
- K59
- Other functional intestinal disorders
- K59.1
- Functional diarrhea
- K63.8
- Other specified diseases of intestine